drug · small molecule
patient view →levodopa
Marketedupdated 2mo agoby PureIMS BV🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for parkinson disease and injury and 22 investigational indications.
indications
investigational
Parkinson's Disease
targets
D(3) dopamine receptor
all catalysts(5)
approval · 5
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that